(COVID Version) Global Active Pharmaceutical Ingredient Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use

November 2021 | 110 pages | ID: C0BA79B30EB1EN
99Strategy

Abstracts

SUMMARY

Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug.

The report forecast global Active Pharmaceutical Ingredient market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021E-2026F due to coronavirus situation.

The report offers detailed coverage of Active Pharmaceutical Ingredient industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Active Pharmaceutical Ingredient by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

First, this report covers the present status and the future prospects of the global Active Pharmaceutical Ingredient market for 2016-2025.

And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

At the same time, we classify Active Pharmaceutical Ingredient according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Finally, the report provides detailed profile and data information analysis of leading Active Pharmaceutical Ingredient company.

Key Content of Chapters as follows (Including and can be customized) :

Part 1:

Market Overview, Development, and Segment by Type, Application & Region

Part 2:

Company information, Sales, Cost, Margin etc.

Part 3:

Global Market by company, Type, Application & Geography

Part 4:

Asia-Pacific Market by Type, Application & Geography

Part 5:

Europe Market by Type, Application & Geography

Part 6:

North America Market by Type, Application & Geography

Part 7:

South America Market by Type, Application & Geography

Part 8:

Middle East & Africa Market by Type, Application & Geography

Part 9:

Market Features

Part 10:

Investment Opportunity

Part 11:

Conclusion

Market Segment as follows:

By Region

• Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America[United States, Canada, Mexico]
• Middle East & Africa[GCC, North Africa, South Africa]
• South America[Brazil, Argentina, Columbia, Chile, Peru]

Key Companies

• Teva
• Novartis
• Pfizer
• Johnson & Johnson
• Mylan
• North China Pharmaceutical Group
• Dr. Reddy’s Laboratories
• Roche
• Aurobindo pharma
• Sun Pharmaceutical Industries
• Boehringer Ingelheim GmbH
• Bayer
• BASF
• DSM
• Zhejiang Medicine
• Biocon
• Johnson Matthey
• Hisun Pharmacy
• Cambrex
• Shandong Xinhua Pharmaceutical
• Lonza group
• Huahai Pharmaceutical
• Haerbin Pharmaceutical Group
• Cipla
• Tian Yao
• Lupin
• North East Pharmaceutical
• Albemarle
• Shandong Lukang Pharmaceutical
• Jiangsu Hengrui Medicine
• Bachem

Market by Type

• Synthetic API
• Biotech API
• Others

Market by Application

• Non-steroidal Anti-inflammatory Drugs (NSAIDs)
• Oncology Drugs
• Anti-diabetic Drugs
• Cardiovascular Drugs
• Central Nervous System Drugs (CNS Drugs)
• Musculoskeletal Drugs
• Other Drugs

Contents

PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
  1.2.1 Current Situation
  1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Active Pharmaceutical Ingredient
Figure Global Active Pharmaceutical Ingredient Market Share by Type in 2020
1.4 By Application
Table Application of Active Pharmaceutical Ingredient
Figure Global Active Pharmaceutical Ingredient Market Share by Application in 2020
1.5 By Region
Figure Global Active Pharmaceutical Ingredient Market Share by Region in 2020
Figure Asia Active Pharmaceutical Ingredient Market Share by Region in 2020

PART 2 KEY COMPANIES

2.1 Teva
  2.1.1 Company Profile
Table Teva Overview List
  2.1.2 Products & Services Overview
  2.1.3 Sales Data List
Table Active Pharmaceutical Ingredient Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
2.2 Novartis
2.3 Pfizer
2.4 Johnson & Johnson
2.5 Mylan
2.6 North China Pharmaceutical Group
2.7 Dr. Reddy’s Laboratories
2.8 Roche
2.9 Aurobindo pharma
2.10 Sun Pharmaceutical Industries
2.11 Boehringer Ingelheim GmbH
2.12 Bayer
2.13 BASF
2.14 DSM
2.15 Zhejiang Medicine
2.16 Biocon
2.17 Johnson Matthey
2.18 Hisun Pharmacy
2.19 Cambrex
2.20 Shandong Xinhua Pharmaceutical
2.21 Lonza group
2.22 Huahai Pharmaceutical
2.23 Haerbin Pharmaceutical Group
2.24 Cipla
2.25 Tian Yao
2.26 Lupin
2.27 North East Pharmaceutical
2.28 Albemarle
2.29 Shandong Lukang Pharmaceutical
2.30 Jiangsu Hengrui Medicine
2.31 Bachem

PART 3 GLOBAL MARKET STATUS AND FUTURE FORECAST

3.1 Global Market by Region
Table Global Active Pharmaceutical Ingredient Market by Region, 2016-2020 (Million USD)
Figure Global Active Pharmaceutical Ingredient Market Share by Region in 2020 (Million USD)
Table Global Active Pharmaceutical Ingredient Market by Region, 2016-2020 (Volume)
Figure Global Active Pharmaceutical Ingredient Market Share by Region in 2020 (Volume)
Table Price List by Region, 2016-2020
3.2 Global Market by Company
Table Global Active Pharmaceutical Ingredient Market by Company, 2016-2020 (Million USD)
Figure Global Active Pharmaceutical Ingredient Market Share by Company in 2020 (Million USD)
Table Global Active Pharmaceutical Ingredient Market by Company, 2016-2020 (Volume)
Figure Global Active Pharmaceutical Ingredient Market Share by Company in 2020 (Volume)
Table Price List by Company, 2016-2020
3.3 Global Market by Type
Table Global Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Million USD)
Figure Global Active Pharmaceutical Ingredient Market Share by Type in 2020 (Million USD)
Table Global Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Volume)
Figure Global Active Pharmaceutical Ingredient Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
3.4 Global Market by Application
Table Global Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Million USD)
Figure Global Active Pharmaceutical Ingredient Market Share by Application in 2020 (Million USD)
Table Global Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Volume)
Figure Global Active Pharmaceutical Ingredient Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
3.5 Global Market by Forecast
Figure Global Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Global Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)

PART 4 ASIA-PACIFIC MARKET STATUS AND FUTURE FORECAST

4.1 Asia-Pacific Market by Type
Table Asia-Pacific Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Million USD)
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Share by Type in 2020 (Million USD)
Table Asia-Pacific Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Volume)
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Million USD)
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Share by Application in 2020 (Million USD)
Table Asia-Pacific Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Volume)
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
4.3 Asia-Pacific Market by Geography
  4.3.1 China Market Status and Future Forecast
Figure China Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure China Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure China Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure China Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Southeast Asia Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Southeast Asia Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Southeast Asia Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  4.3.3 India Market Status and Future Forecast
Figure India Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure India Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure India Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure India Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  4.3.4 Japan Market Status and Future Forecast
Figure Japan Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Japan Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Japan Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Japan Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  4.3.5 Korea Market Status and Future Forecast
Figure Korea Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Korea Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Korea Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Korea Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Oceania Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Oceania Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Oceania Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)

PART 5 EUROPE MARKET STATUS AND FUTURE FORECAST

5.1 Europe Market by Type
Table Europe Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Million USD)
Figure Europe Active Pharmaceutical Ingredient Market Share by Type in 2020 (Million USD)
Table Europe Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Volume)
Figure Europe Active Pharmaceutical Ingredient Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
5.2 Europe Market by Application
Table Europe Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Million USD)
Figure Europe Active Pharmaceutical Ingredient Market Share by Application in 2020 (Million USD)
Table Europe Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Volume)
Figure Europe Active Pharmaceutical Ingredient Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
5.3 Europe Market by Geography
  5.3.1 Germany Market Status and Future Forecast
Figure Germany Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Germany Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Germany Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Germany Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  5.3.2 UK Market Status and Future Forecast
Figure UK Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure UK Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure UK Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure UK Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  5.3.3 France Market Status and Future Forecast
Figure France Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure France Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure France Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure France Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  5.3.4 Italy Market Status and Future Forecast
Figure Italy Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Italy Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Italy Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Italy Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  5.3.5 Russia Market Status and Future Forecast
Figure Russia Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Russia Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Russia Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Russia Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  5.3.6 Spain Market Status and Future Forecast
Figure Spain Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Spain Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Spain Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Spain Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Netherlands Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Netherlands Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Netherlands Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Turkey Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Turkey Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Turkey Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Switzerland Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Switzerland Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Switzerland Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
5.4 Europe Market by Forecast
Figure Europe Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Europe Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)

PART 6 NORTH AMERICA MARKET STATUS AND FUTURE FORECAST

6.1 North America Market by Type
Table North America Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Million USD)
Figure North America Active Pharmaceutical Ingredient Market Share by Type in 2020 (Million USD)
Table North America Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Volume)
Figure North America Active Pharmaceutical Ingredient Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
6.2 North America Market by Application
Table North America Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Million USD)
Figure North America Active Pharmaceutical Ingredient Market Share by Application in 2020 (Million USD)
Table North America Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Volume)
Figure North America Active Pharmaceutical Ingredient Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
6.3 North America Market by Geography
  6.3.1 United States Market Status and Future Forecast
Figure United States Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure United States Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure United States Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure United States Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  6.3.2 Canada Market Status and Future Forecast
Figure Canada Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Canada Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Canada Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Canada Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Mexico Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Mexico Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Mexico Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
6.4 North America Market by Forecast
Figure North America Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure North America Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)

PART 7 SOUTH AMERICA MARKET STATUS AND FUTURE FORECAST

7.1 South America Market by Type
Table South America Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Million USD)
Figure South America Active Pharmaceutical Ingredient Market Share by Type in 2020 (Million USD)
Table South America Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Volume)
Figure South America Active Pharmaceutical Ingredient Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
7.2 South America Market by Application
Table South America Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Million USD)
Figure South America Active Pharmaceutical Ingredient Market Share by Application in 2020 (Million USD)
Table South America Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Volume)
Figure South America Active Pharmaceutical Ingredient Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
7.3 South America Market by Geography
  7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Brazil Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Brazil Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Brazil Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Argentina Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Argentina Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Argentina Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Columbia Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Columbia Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Columbia Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  7.3.4 Chile Market Status and Future Forecast
Figure Chile Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Chile Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Chile Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Chile Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  7.3.5 Peru Market Status and Future Forecast
Figure Peru Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Peru Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Peru Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Peru Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
7.4 South America Market by Forecast
Figure South America Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure South America Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)

PART 8 MIDDLE EAST & AFRICA MARKET STATUS AND FUTURE FORECAST

8.1 Middle East & Africa Market by Type
Table Middle East & Africa Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Million USD)
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Share by Type in 2020 (Million USD)
Table Middle East & Africa Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Volume)
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Million USD)
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Share by Application in 2020 (Million USD)
Table Middle East & Africa Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Volume)
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
8.3 Middle East & Africa Market by Geography
  8.3.1 GCC Market Status and Future Forecast
Figure GCC Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure GCC Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure GCC Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure GCC Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  8.3.2 North Africa Market Status and Future Forecast
Figure North Africa Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure North Africa Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure North Africa Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure North Africa Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
  8.3.3 South Africa Market Status and Future Forecast
Figure South Africa Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure South Africa Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure South Africa Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure South Africa Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
8.4 Middle East & Africa Market by Forecast
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)

PART 9 MARKET FEATURES

9.1 Product Features
9.2 Price Features
9.3 Channel Features
9.4 Purchasing Features

PART 10 INVESTMENT OPPORTUNITY

10.1 Regional Investment Opportunity
10.2 Industry Investment Opportunity

PART 11 CORONAVIRUS IMPACT

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 CONCLUSION

List Of Tables

LIST OF TABLES
Table Type of Active Pharmaceutical Ingredient
Table Application of Active Pharmaceutical Ingredient
Table Teva Overview List
Table Active Pharmaceutical Ingredient Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Life & Medical Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Volume Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table xxx Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table xx% Business Operation of North China Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 17 Business Operation of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 7 Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 0 Business Operation of Aurobindo pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 6 Business Operation of Sun Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 2750 Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 3300 Business Operation of Bayer (Sales Revenue, Cost, Gross Margin)
Table 4290 Business Operation of BASF (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 120 Business Operation of DSM (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Zhejiang Medicine (Sales Revenue, Cost, Gross Margin)
Table Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug. Business Operation of Biocon (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Johnson Matthey (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Hisun Pharmacy (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Cambrex (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Shandong Xinhua Pharmaceutical (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Lonza group (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Huahai Pharmaceutical (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Haerbin Pharmaceutical Group (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Cipla (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Tian Yao (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Lupin (Sales Revenue, Cost, Gross Margin)
Table Business Operation of North East Pharmaceutical (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Albemarle (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Shandong Lukang Pharmaceutical (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Jiangsu Hengrui Medicine (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Bachem (Sales Revenue, Cost, Gross Margin)
Table Global Active Pharmaceutical Ingredient Market by Region, 2016-2020 (Million USD)
Table Global Active Pharmaceutical Ingredient Market by Region, 2016-2020 (Volume)
Table Price List by Region, 2016-2020
Table Global Active Pharmaceutical Ingredient Market by Company, 2016-2020 (Million USD)
Table Global Active Pharmaceutical Ingredient Market by Company, 2016-2020 (Volume)
Table Price List by Company, 2016-2020
Table Global Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Million USD)
Table Global Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Volume)
Table Price List by Type, 2016-2020
Table Global Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Million USD)
Table Global Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Volume)
Table Price List by Application, 2016-2020
Table Asia-Pacific Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Million USD)
Table Asia-Pacific Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Volume)
Table Price List by Type, 2016-2020
Table Asia-Pacific Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Million USD)
Table Asia-Pacific Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Volume)
Table Price List by Application, 2016-2020
Table Europe Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Million USD)
Table Europe Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Volume)
Table Price List by Type, 2016-2020
Table Europe Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Million USD)
Table Europe Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Volume)
Table Price List by Application, 2016-2020
Table North America Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Million USD)
Table North America Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Volume)
Table Price List by Type, 2016-2020
Table North America Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Million USD)
Table North America Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Volume)
Table Price List by Application, 2016-2020
Table South America Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Million USD)
Table South America Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Volume)
Table Price List by Type, 2016-2020
Table South America Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Million USD)
Table South America Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Volume)
Table Price List by Application, 2016-2020
Table Middle East & Africa Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Million USD)
Table Middle East & Africa Active Pharmaceutical Ingredient Market by Type, 2016-2020 (Volume)
Table Price List by Type, 2016-2020
Table Middle East & Africa Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Million USD)
Table Middle East & Africa Active Pharmaceutical Ingredient Market by Application, 2016-2020 (Volume)
Table Price List by Application, 2016-2020

List Of Figures

LIST OF FIGURES
Figure Global Active Pharmaceutical Ingredient Market Share by Type in 2020
Figure Global Active Pharmaceutical Ingredient Market Share by Application in 2020
Figure Global Active Pharmaceutical Ingredient Market Share by Region in 2020
Figure Asia Active Pharmaceutical Ingredient Market Share by Region in 2020
Figure Global Active Pharmaceutical Ingredient Market Share by Region in 2020 (Million USD)
Figure Global Active Pharmaceutical Ingredient Market Share by Region in 2020 (Volume)
Figure Global Active Pharmaceutical Ingredient Market Share by Company in 2020 (Million USD)
Figure Global Active Pharmaceutical Ingredient Market Share by Company in 2020 (Volume)
Figure Global Active Pharmaceutical Ingredient Market Share by Type in 2020 (Million USD)
Figure Global Active Pharmaceutical Ingredient Market Share by Type in 2020 (Volume)
Figure Global Active Pharmaceutical Ingredient Market Share by Application in 2020 (Million USD)
Figure Global Active Pharmaceutical Ingredient Market Share by Application in 2020 (Volume)
Figure Global Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Global Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Share by Type in 2020 (Million USD)
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Share by Type in 2020 (Volume)
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Share by Application in 2020 (Million USD)
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Share by Application in 2020 (Volume)
Figure China Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure China Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure China Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure China Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Southeast Asia Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Southeast Asia Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Southeast Asia Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Southeast Asia Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure India Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure India Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure India Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure India Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Japan Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Japan Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Japan Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Japan Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Korea Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Korea Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Korea Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Korea Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Oceania Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Oceania Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Oceania Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Oceania Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Europe Active Pharmaceutical Ingredient Market Share by Type in 2020 (Million USD)
Figure Europe Active Pharmaceutical Ingredient Market Share by Type in 2020 (Volume)
Figure Europe Active Pharmaceutical Ingredient Market Share by Application in 2020 (Million USD)
Figure Europe Active Pharmaceutical Ingredient Market Share by Application in 2020 (Volume)
Figure Germany Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Germany Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Germany Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Germany Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure UK Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure UK Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure UK Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure UK Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure France Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure France Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure France Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure France Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Italy Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Italy Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Italy Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Italy Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Russia Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Russia Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Russia Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Russia Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Spain Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Spain Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Spain Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Spain Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Netherlands Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Netherlands Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Netherlands Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Netherlands Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Turkey Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Turkey Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Turkey Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Turkey Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Switzerland Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Switzerland Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Switzerland Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Switzerland Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Europe Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Europe Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure North America Active Pharmaceutical Ingredient Market Share by Type in 2020 (Million USD)
Figure North America Active Pharmaceutical Ingredient Market Share by Type in 2020 (Volume)
Figure North America Active Pharmaceutical Ingredient Market Share by Application in 2020 (Million USD)
Figure North America Active Pharmaceutical Ingredient Market Share by Application in 2020 (Volume)
Figure United States Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure United States Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure United States Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure United States Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Canada Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Canada Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Canada Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Canada Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Mexico Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Mexico Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Mexico Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Mexico Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure North America Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure North America Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure South America Active Pharmaceutical Ingredient Market Share by Type in 2020 (Million USD)
Figure South America Active Pharmaceutical Ingredient Market Share by Type in 2020 (Volume)
Figure South America Active Pharmaceutical Ingredient Market Share by Application in 2020 (Million USD)
Figure South America Active Pharmaceutical Ingredient Market Share by Application in 2020 (Volume)
Figure Brazil Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Brazil Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Brazil Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Brazil Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Argentina Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Argentina Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Argentina Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Argentina Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Columbia Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Columbia Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Columbia Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Columbia Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Chile Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Chile Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Chile Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Chile Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Peru Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure Peru Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure Peru Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Peru Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure South America Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure South America Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Share by Type in 2020 (Million USD)
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Share by Type in 2020 (Volume)
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Share by Application in 2020 (Million USD)
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Share by Application in 2020 (Volume)
Figure GCC Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure GCC Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure GCC Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure GCC Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure North Africa Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure North Africa Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure North Africa Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure North Africa Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure South Africa Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Million USD)
Figure South Africa Active Pharmaceutical Ingredient Market Market Status, 2016-2020 (Volume)
Figure South Africa Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure South Africa Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Million USD)
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Forecast, 2021E-2026F (Volume)